+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 70Years
All Genders
ID06675604

Study to Develop and Validate LEOPARD AI Models Predicting Mortality and Dropout in Adults Awaiting Liver Transplantation for Cirrhosis, End-Stage Liver Diseases, or Liver Cancer

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-07-29

4500

Participants Needed

53

Research Sites

48 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a large-scale European observational study as part of the LEOPARD project to improve predictions of mortality and dropout among liver transplant candidates. The study focuses on patients with decompensated cirrhosis, other end-stage chronic liver diseases, or hepatocellular carcinoma HCC who are on transplant waiting lists. Current MELD-based liver graft allocation systems have become less accurate, and there are wide differences in patient outcomes across countries, which this study aims to address by developing new AI-based predictive models. The study involves collecting prospective healthcare data from 4,500 patients across 50 centers in seven European countries, divided into a training set of 3,000 patients and a validation set of 1,500 patients. Patients are categorized into three subsets based on their primary diagnosis decompensated cirrhosis, other chronic liver diseases requiring transplantation, and HCC. Data collection includes information from listing until death, dropout, transplantation, or up to 12 months post-listing or transplantation. Participants provide data that researchers use to develop and validate predictive models of mortality or dropout from the transplant waiting list. The main outcome is a composite measure of mortality or dropout due to worsening illness at various time points after listing. Secondary outcomes track causes and timing of dropout, transplantation timing, post-transplant survival, and HCC recurrence. The study spans from February 2025 to February 2029, with ongoing assessments up to 12 months after listing or transplantation.

CONDITIONS

Brief Title

LEOPARD Training and Validation Data Collection Study

Research Team

C

Christophe DUVOUX, MD-PHD

N

Nihel BERREBEH, Project Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here